Back to Career News

Here are the 5 Pharma Giants that will be Affected by the Ban on FDCs

October 03, 2018

Here are the 5 Pharma Giants that will be Affected by the Ban on FDCs
With the health ministry imposing a ban on 328 fixed-dose combination (FDC) drugs, 5 of the biggest pharmaceutical companies find themselves in jeopardy. These are Macleods Pharmaceuticals, FDC Ltd., Mankind Pharmaceuticals, Medley Pharmaceuticals, and Alkem. Out of these, Macleods Pharmaceuticals has the largest share in the market and does nearly 3 billion in sales in a year. 

The banned 328 FDCs make for 0.8% of the market share at 10.40 billion in sales. The ban itself was imposed because the ministry found these drugs to be irrational and lacking any therapeutic justification.

Photo on Visual Hunt

Recommended for you ...

Axis Bank and Mastercard Launch Premium Credit Card for Small Business Owners
Axis Bank and Mastercard Launch Premium Credit Card for Small Business Owners

September 26, 2024

Banks Report Over 15% Growth in New Credit Card Additions: RBI Data
Banks Report Over 15% Growth in New Credit Card Additions: RBI Data

September 26, 2024

National Company Law Tribunal (NCLT) Approves Merger of IDFC and IDFC First Bank
National Company Law Tribunal (NCLT) Approves Merger of IDFC and IDFC First Bank

September 25, 2024

Chat on WhatsApp